Hepatitis C Drugs
- All
- News
- Videos
-
Understanding The Link Between Hepatitis And Liver Cancer
What many people don't realise is that hepatitis infections can quietly damage the liver over time, leading to serious conditions, including cirrhosis and eventually, hepatocellular carcinoma (HCC), the most common type of liver cancer.
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India
A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said.
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For Covid Treatment
Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.
-
World Day Against Drug Abuse: UN Says, "Better Knowledge For Better Care"
World drug abuse day 2020: Around 35.6 million people across the world are victims of drug abuse according to the World Drug Report 2020, which is published by the United Nations Office on Drugs and Crime. Young adults and teenagers account for the largest share of those using drugs and most of them suffer from HIV, Hepatitis C and other related di...
-
Hepatitis C Drugs May Help Fight COVID-19, Suggests Study
Several drugs approved for the treatment of hepatitis C viral infection have been identified as potential candidates against COVID-19 caused by the SARS-CoV-2 coronavirus, according to a study based on extensive calculations using supercomputer simulations.
-
World Hepatitis Day: Types Of Hepatitis And 6 Other Things You Must Know
World Hepatitis Day: Hepatitis is essentially inflammation of the liver. It is most commonly caused by hepatitis virus. However, other toxic substances like alcohol, certain medications and drugs can also lead to hepatitis.
-
Women: The Silent Victims Of Punjab's Drug Crisis
Amritsar, Punjab: In Amritsar’s Ajnala town, close to Pakistan’s border, 23-year-old Pooja (name changed), has been coping with her husband Parambir’s drug addiction for over five years. “After every treatment session, he promises to quit. But a few days after we are back home, he is back to the habit,” she says, despair and worry written...
-
World Hepatitis Day: Mylan Launches Tablets For Treatment Of Hepatitis C
It's estimated that over 70 million people around the world have chronic Hepatitis C infection and nearly 400,000 people die each year from Hepatitis C-related liver diseases. Ahead of World Hepatitis Day the drug has now been launched to treat it.
-
Hepatitis C Drugs In India Are Cost Effective, Shows Study
Boston: Hepatitis C virus drugs available in India not only increase life expectancy but also reduce lifetime health care costs by over USD 1,300 per person. Researchers found that the generic directly-acting antiviral (DAA) treatments available in India are cost effective. “More than 9 million people are infected with Hepatitis C virus (HCV) in ...
-
Lupin, 5 Other Pharma Firms Ink Licensing Pact With Medicines Patent Pool
Indian pharma firms Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila are among the seven drug makers which have signed licensing pact with UN-backed Medicines Patent Pool (MPP) for producing HIV and hepatitis C drugs.
-
Zydus Inks Pact With Medicines Patent Pool For Hepatitis C Drug
Drug firm Zydus Cadila has inked a generic manufacturing pact with the Medicines Patent Pool for manufacturing global pharma major Bristol-Myers Squibb's daclatasvir tablets used in the treatment of Hepatitis C.
-
India May Soon Get Treatment For Hepatitis C
A latest breakthrough treatment for the deadly Hepatitis C virus could soon be available in India as 11 Indian firms have been given licenses by its American manufacturer following an approval from US authorities.
-
Drug Price Controller Fixes Price Of 70 Drug Formulation Packs
Last month, NPPA had fixed the ceiling price of as many as 103 drug formulation packs, including those used for treating HIV/AIDS, bacterial infections, tuberculosis, high blood pressure, epilepsy, Hepatitis C and diabetes.
-
Prices of 103 Formulation Packs to Get Cheaper
With the NPPA's move, some of the key drugs such as Tenofovir, Lamivudine, Raltegravir used for treatment of HIV/AIDS and Sofosbuvir, which is used against Hepatitis C will become cheaper.
-
Natco Pharma Signs Agreement for Manufacturing, Sale of Hepatitis C Drug
Natco Pharma has signed a non-exclusive licensing agreement with the Medicines Patent Pool (MPP) and Bristol-Myers Squibb to manufacture and sell generic versions of Daclatasvir, used for the treatment of chronic hepatitis C.
-
Understanding The Link Between Hepatitis And Liver Cancer
What many people don't realise is that hepatitis infections can quietly damage the liver over time, leading to serious conditions, including cirrhosis and eventually, hepatocellular carcinoma (HCC), the most common type of liver cancer.
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For COVID-19 In India
A single dose of the Hepatitis C drug when taken early could help COVID-19 patients recover faster and avoid complications seen in the advanced stages of the disease, Cadila said.
-
Cadila Seeks Nod To Repurpose Hepatitis C Drug For Covid Treatment
Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.
-
World Day Against Drug Abuse: UN Says, "Better Knowledge For Better Care"
World drug abuse day 2020: Around 35.6 million people across the world are victims of drug abuse according to the World Drug Report 2020, which is published by the United Nations Office on Drugs and Crime. Young adults and teenagers account for the largest share of those using drugs and most of them suffer from HIV, Hepatitis C and other related di...
-
Hepatitis C Drugs May Help Fight COVID-19, Suggests Study
Several drugs approved for the treatment of hepatitis C viral infection have been identified as potential candidates against COVID-19 caused by the SARS-CoV-2 coronavirus, according to a study based on extensive calculations using supercomputer simulations.
-
World Hepatitis Day: Types Of Hepatitis And 6 Other Things You Must Know
World Hepatitis Day: Hepatitis is essentially inflammation of the liver. It is most commonly caused by hepatitis virus. However, other toxic substances like alcohol, certain medications and drugs can also lead to hepatitis.
-
Women: The Silent Victims Of Punjab's Drug Crisis
Amritsar, Punjab: In Amritsar’s Ajnala town, close to Pakistan’s border, 23-year-old Pooja (name changed), has been coping with her husband Parambir’s drug addiction for over five years. “After every treatment session, he promises to quit. But a few days after we are back home, he is back to the habit,” she says, despair and worry written...
-
World Hepatitis Day: Mylan Launches Tablets For Treatment Of Hepatitis C
It's estimated that over 70 million people around the world have chronic Hepatitis C infection and nearly 400,000 people die each year from Hepatitis C-related liver diseases. Ahead of World Hepatitis Day the drug has now been launched to treat it.
-
Hepatitis C Drugs In India Are Cost Effective, Shows Study
Boston: Hepatitis C virus drugs available in India not only increase life expectancy but also reduce lifetime health care costs by over USD 1,300 per person. Researchers found that the generic directly-acting antiviral (DAA) treatments available in India are cost effective. “More than 9 million people are infected with Hepatitis C virus (HCV) in ...
-
Lupin, 5 Other Pharma Firms Ink Licensing Pact With Medicines Patent Pool
Indian pharma firms Aurobindo, Emcure, Hetero Labs, Laurus Labs, Lupin and Zydus Cadila are among the seven drug makers which have signed licensing pact with UN-backed Medicines Patent Pool (MPP) for producing HIV and hepatitis C drugs.
-
Zydus Inks Pact With Medicines Patent Pool For Hepatitis C Drug
Drug firm Zydus Cadila has inked a generic manufacturing pact with the Medicines Patent Pool for manufacturing global pharma major Bristol-Myers Squibb's daclatasvir tablets used in the treatment of Hepatitis C.
-
India May Soon Get Treatment For Hepatitis C
A latest breakthrough treatment for the deadly Hepatitis C virus could soon be available in India as 11 Indian firms have been given licenses by its American manufacturer following an approval from US authorities.
-
Drug Price Controller Fixes Price Of 70 Drug Formulation Packs
Last month, NPPA had fixed the ceiling price of as many as 103 drug formulation packs, including those used for treating HIV/AIDS, bacterial infections, tuberculosis, high blood pressure, epilepsy, Hepatitis C and diabetes.
-
Prices of 103 Formulation Packs to Get Cheaper
With the NPPA's move, some of the key drugs such as Tenofovir, Lamivudine, Raltegravir used for treatment of HIV/AIDS and Sofosbuvir, which is used against Hepatitis C will become cheaper.
-
Natco Pharma Signs Agreement for Manufacturing, Sale of Hepatitis C Drug
Natco Pharma has signed a non-exclusive licensing agreement with the Medicines Patent Pool (MPP) and Bristol-Myers Squibb to manufacture and sell generic versions of Daclatasvir, used for the treatment of chronic hepatitis C.
